webinar register page

Webinar banner
Pressure rising: clinical controversies and updates in hypertension
This event will be hosted by the Heart Foundation in partnership with the World Heart Federation and the High Blood Pressure Research Council of Australia, and chaired by Prof. Garry Jennings, Chief Medical Advisor and Interim CEO of the Heart Foundation.

Our global expert panel will discuss:
• Controversies in BP targets and implications for practice post SPRINT trial
• Latest advice for the diagnosis and management of resistant hypertension
• Latest advice on out-of-office blood pressure monitoring
• Digital health tools on the horizon for CVD prevention and monitoring
• Applying new evidence to clinical practice to promote structured CVD prevention strategies

This activity is accredited by the RACGP CPD program for 2 CPD points (Activity no. 295128). Education provider: Scius Healthcare Solutions.

Sep 29, 2021 08:00 PM in Canberra, Melbourne, Sydney

Webinar logo
* Required information


Prof. Rhian Touyz
Executive Director and Chief Scientific Officer @Research Institute of McGill University Health Centre, Montreal, Canada
Dr Touyz is the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre and the Dr. Phil Gold Chair in Medicine, McGill University, Montreal, Canada. Until September 2021, she was the Director of the Institute of Cardiovascular & Medical Sciences (ICAMS) and British Heart Foundation Chair and Professor of Cardiovascular Medicine, Univ of Glasgow. From 2005-2011 she held a Canada Research Chair in Hypertension (Tier 1). She is a clinician-scientist with an interest in molecular and vascular mechanisms of hypertension. She contributes to best clinical practice and co-chaired CHEP for clinical guidelines. She is a committee member for Guidelines of the European Society of Cardiology. She played major leadership roles in premier hypertension organisations: President-Canadian Hypertension Society, Chair-High BP Research Council, President-International Society of Hypertension and President-European Council for Cardiovascular Research.
Prof. Markus Schlaich
Dobney Chair in Clinical Research @The University of Western Australia | President @High Blood Pressure Research Council of Australia
Professor Schlaich is a renal physician and a European Society of Hypertension (ESH) accredited hypertension specialist with a strong background in clinical research. His main scientific interests focus on pathophysiologic aspects of hypertension, involvement of the kidneys and hypertension mediated organ damage. He has authored more than 400 articles and book chapters in peer reviewed journals and has received several research prizes and awards. He currently serves as President of the High Blood Pressure Research Council of Australia and is on the Scientific Council of the International Society of Hypertension. He is a founding member of the European Society of Hypertension Working Group on Interventional Treatment of Hypertension. He serves on the Editorial Board of Hypertension and Journal of Hypertension.
Prof. James Sharman
Deputy Director and Head of the Blood Pressure Research Group @Menzies Institute for Medical Research, University of Tasmania
James is Professor of Medical Research, Deputy Director and head of the Blood Pressure Research Group at the Menzies Institute for Medical Research, Hobart. His research program is dedicated to reducing blood pressure related premature death and disability through research that traverses basic human blood pressure physiology to public health translation. James has led national and international position statements on blood pressure measurement and accuracy. He has published more than 250 papers and is an investigator on cardiovascular research grant funding over $10 million.
Prof. Nick Zwar
GP and Executive Dean of the Faculty of Health Sciences and Medicine @Bond University
Nick Zwar has extensive experience in medicine as a general practitioner and as a primary health care teacher and researcher. He has a national and international reputation in health services research on prevention and management of chronic illness, with a focus on respiratory and cardiovascular diseases. Nick has led and contributed to several sets of Australian and international clinical practice guidelines and has over 200 peer-reviewed publications. Nick was previously Dean of Medicine at University of Wollongong and is currently the Executive Dean of the Faculty of Health Sciences and Medicine at Bond University.
Prof. Garry Jennings
Chief Medical Advisor and Interim CEO @Heart Foundation
Professor Garry Jennings is the Chief Medical Advisor of the Heart Foundation as well as Senior Director at the Baker Heart and Diabetes Research Institute where he was Director and CEO from 2001–15. He is also the Executive Director of Sydney Health Partners. A cardiologist, over 500 of his publications have been cited more than 25,000 times on subjects ranging from prevention, pathophysiology and treatment of cardiovascular disease to aboriginal health and health policy.